Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
PCa cells have strengthened ability to escape NK cell attack due to NANOG.
»
10/16/19
Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30
Patients with RS 26–30 had more aggressive tumor characteristics.
»
10/16/19
Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling
SUV39H2 regulated hedgehog signaling by repressing HHIP expression.
»
10/16/19
Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin
Increased degradation of VE-cadherin also observed.
»
10/16/19
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
Most significant prognostic factor was type of healthcare system.
»
10/16/19
The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
Multimodal treatment achieved most effective reduction of clonogenicity.
»
10/21/19
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
Enzalutamide inhibited growth of VCaP scr cells more effectively than shERG cells.
»
10/21/19
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
Induced endothelial expression of PSMA efficiently addressed by radiolabeled PSMA-specific ligands.
»
10/22/19
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
good agreement achieved for abutment of tumor to arterial structures.
»
10/22/19
Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program
79% of participants found genetic counselling to be helpful.
»
10/23/19
< Prev
Next >